1. Home
  2. TPST vs AERT Comparison

TPST vs AERT Comparison

Compare TPST & AERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • AERT
  • Stock Information
  • Founded
  • TPST 2011
  • AERT 2012
  • Country
  • TPST United States
  • AERT Singapore
  • Employees
  • TPST N/A
  • AERT N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • AERT Professional Services
  • Sector
  • TPST Health Care
  • AERT Consumer Discretionary
  • Exchange
  • TPST Nasdaq
  • AERT Nasdaq
  • Market Cap
  • TPST 33.0M
  • AERT 38.3M
  • IPO Year
  • TPST N/A
  • AERT N/A
  • Fundamental
  • Price
  • TPST $7.09
  • AERT $1.06
  • Analyst Decision
  • TPST Hold
  • AERT
  • Analyst Count
  • TPST 3
  • AERT 0
  • Target Price
  • TPST $30.00
  • AERT N/A
  • AVG Volume (30 Days)
  • TPST 245.0K
  • AERT 291.5K
  • Earning Date
  • TPST 08-07-2025
  • AERT 08-14-2025
  • Dividend Yield
  • TPST N/A
  • AERT N/A
  • EPS Growth
  • TPST N/A
  • AERT N/A
  • EPS
  • TPST N/A
  • AERT 0.47
  • Revenue
  • TPST N/A
  • AERT $70,851,000.00
  • Revenue This Year
  • TPST N/A
  • AERT N/A
  • Revenue Next Year
  • TPST N/A
  • AERT N/A
  • P/E Ratio
  • TPST N/A
  • AERT $2.25
  • Revenue Growth
  • TPST N/A
  • AERT 4.38
  • 52 Week Low
  • TPST $5.35
  • AERT $0.46
  • 52 Week High
  • TPST $30.03
  • AERT $2.93
  • Technical
  • Relative Strength Index (RSI)
  • TPST 49.91
  • AERT 62.36
  • Support Level
  • TPST $6.87
  • AERT $1.03
  • Resistance Level
  • TPST $7.25
  • AERT $1.52
  • Average True Range (ATR)
  • TPST 0.67
  • AERT 0.20
  • MACD
  • TPST -0.02
  • AERT 0.02
  • Stochastic Oscillator
  • TPST 11.20
  • AERT 47.36

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

Share on Social Networks: